In its final Phase III clinical trial, a new drug for treating rheumatoid arthritis has proved to be at least as effective as the current “gold standard” treatment for this autoimmune disease. This opens up new treatment options for affected patients. The results of the international multicentre study led by MedUni Vienna were recently published […]
Read More… from New drug expands treatment opportunities for rheumatoid arthritis
Interrupting treatment of immune-suppressing medicines, doubles antibody response to COVID-19 booster vaccination: A major clinical trial, led by experts at the University of Nottingham working in partnership with several Universities and NHS hospitals, has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster […]
Read More… from Immune-suppressing drugs and booster vaccination
Working to stop MS in its tracks: On World Brain Day (22 July), work continues to diagnose multiple sclerosis (MS) earlier, provide access to life-changing treatments and improve the quality of life for those living with the condition By Professor Tissa Wijeratne, University of Melbourne and Professor Wolfgang Grisold, World Federation of Neurology Health, as […]
What is multiple sclerosis? Multiple sclerosis is a chronic and progressive neurological disease that results in neuronal cell death, which can lead to a variety of symptoms. Find more videos at https://www.osmosis.org/product/library. Transcript Multiple sclerosis is a demyelinating disease of the central nervous system, which includes the brain and the spinal cord. Myelin is the […]
Read More… from Multiple sclerosis – causes, symptoms, diagnosis, treatment, pathology
This week marks Rheumatoid Arthritis Awareness Week, a week dedicated to increasing the profile of a frequently misunderstood disease that affects over 430,000 people in the UK. It is a common misconception that arthritis is simply a condition of the elderly, a consequence of age and subsequent wear and tear of the joints. However, Rheumatoid […]
Study discovers the link between an the anti-inflammatory gut and seratonin. The scientific journal, Cell Metabolism publishes this April, the latest findings from Professor of Immunology Claudia Mauri’s Laboratory in UCL’s Inflammation Department in the Division of Medicine. This study, co-led with Dr Elizabeth Rosser, Senior Research Associate, Immunology Department, reveals a link between the […]